PubMed

The development and testing of a measure assessing clinician beliefs about patient self-management.

Hibbard JH, Collins PA, Mahoney E, Baker LH.

Health Expect. 2009 Nov 10. [Epub ahead of print]PMID: 19906211 [PubMed - as supplied by publisher]Related articles

Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives Workshop 2008.

Okunieff P, Kachnic LA, Constine LS, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL Jr, Philip PA, Raben D, Smalley SR, Swanson GP, Teicher BA, Thomas CR Jr, Vikram B, Zelefsky MJ, Baker LH.

Clin Cancer Res. 2009 Sep 15;15(18):5663-70. Epub 2009 Sep 1.PMID: 19723641 [PubMed - in process]Related articles

Small round cell sarcomas.

Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS.

Semin Oncol. 2009 Aug;36(4):338-46. Review.PMID: 19664494 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

Demetri GD, Chawla SP, von Mehren M, Ritch P, Baker LH, Blay JY, Hande KR, Keohan ML, Samuels BL, Schuetze S, Lebedinsky C, Elsayed YA, Izquierdo MA, Gómez J, Park YC, Le Cesne A.

J Clin Oncol. 2009 Sep 1;27(25):4188-96. Epub 2009 Aug 3.PMID: 19652065 [PubMed - indexed for MEDLINE]Related articles

Pharmacotherapy of sarcoma.

Chugh R, Baker LH.

Expert Opin Pharmacother. 2009 Aug;10(12):1953-63. Review.PMID: 19558336 [PubMed - indexed for MEDLINE]Related articles

Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, Priebat DA, Reinke DK, Thomas DG, Keohan ML, Samuels BL, Baker LH.

J Clin Oncol. 2009 Jul 1;27(19):3148-53. Epub 2009 May 18. Erratum in: J Clin Oncol. 2009 Sep 20;27(27):4630. Myers, Paul A [corrected to Meyers, Paul A]. PMID: 19451433 [PubMed - indexed for MEDLINE]Related articles

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. Epub 2008 Dec 9.PMID: 19066370 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcoma.

Baker LH, Rowinsky EK, Mendelson D, Humerickhouse RA, Knight RA, Qian J, Carr RA, Gordon GB, Demetri GD.

J Clin Oncol. 2008 Dec 1;26(34):5583-8. Epub 2008 Nov 3.PMID: 18981463 [PubMed - indexed for MEDLINE]Related articles

Selection of response criteria for clinical trials of sarcoma treatment.

Schuetze SM, Baker LH, Benjamin RS, Canetta R.

Oncologist. 2008;13 Suppl 2:32-40. Review.PMID: 18434637 [PubMed - indexed for MEDLINE]Related articlesFree article

Myxoid malignant fibrous histiocytoma with multiple primary sites.

Muler JH, Paulino AF, Roulston D, Baker LH.

Sarcoma. 2002;6(1):51-5.PMID: 18521346 [PubMed - in process]Related articlesFree article

Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.

Tawbi H, Thomas D, Lucas DR, Biermann JS, Schuetze SM, Hart AL, Chugh R, Baker LH.

Oncologist. 2008 Apr;13(4):459-66.PMID: 18448562 [PubMed - indexed for MEDLINE]Related articlesFree article

Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.

Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG, Schuetze SM, Baker LH.

Oncologist. 2008 Apr;13(4):451-8.PMID: 18448561 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.

Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED; Southwest Oncology Group Trial 8733.

Cancer. 2008 May 15;112(10):2181-7.PMID: 18404692 [PubMed - indexed for MEDLINE]Related articlesFree article

New agents for sarcoma.

Baker LH.

Clin Adv Hematol Oncol. 2007 Dec;5(12):949-51. No abstract available. PMID: 18277955 [PubMed - indexed for MEDLINE]Related articles

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC.

J Clin Oncol. 2008 Feb 1;26(4):626-32.PMID: 18235122 [PubMed - indexed for MEDLINE]Related articles

Chordoma: the nonsarcoma primary bone tumor.

Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH.

Oncologist. 2007 Nov;12(11):1344-50. Review.PMID: 18055855 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]

Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML.

J Clin Oncol. 2007 Jul 1;25(19):2755-63. Erratum in: J Clin Oncol. 2007 Aug 20;25(24):3790. PMID: 17602081 [PubMed - indexed for MEDLINE]Related articles

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):103-10. Epub 2007 Jun 7.PMID: 17560050 [PubMed - indexed for MEDLINE]Related articles

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.

Chugh R, Wagner T, Griffith KA, Taylor JM, Thomas DG, Worden FP, Leu KM, Zalupski MM, Baker LH.

Cancer. 2007 Jun 1;109(11):2315-22.PMID: 17464949 [PubMed - indexed for MEDLINE]Related articlesFree article

Soft tissue sarcoma.

Demetri GD, Baker LH, Benjamin RS, Casper ES, Conrad EU 3rd, D'Amato GZ, DeLaney TF, Ettinger DS, Heck R Jr, Heslin MJ, Hutchinson RJ, Jacobs CD, Kiel K, Kraybill WG, Letson GD, O'Donnell RJ, Paz IB, Pfeifer J, Pollock RE, Randall RL, Sasson AR, Schupak KD, Tyler DS, von Mehren M, Wayne J; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2007 Apr;5(4):364-99. No abstract available. PMID: 17442230 [PubMed - indexed for MEDLINE]Related articles

Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.

Mensah-Osman EJ, Thomas DG, Tabb MM, Larios JM, Hughes DP, Giordano TJ, Lizyness ML, Rae JM, Blumberg B, Hollenberg PF, Baker LH.

Cancer. 2007 Mar 1;109(5):957-65.PMID: 17279585 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology.

Petrou M, Quint LE, Nan B, Baker LH.

AJR Am J Roentgenol. 2007 Feb;188(2):306-12.PMID: 17242235 [PubMed - indexed for MEDLINE]Related articlesFree article

Gardner's syndrome in a 40-year-old woman: successful treatment of locally aggressive desmoid tumors with cytotoxic chemotherapy.

Bhama PK, Chugh R, Baker LH, Doherty GM.

World J Surg Oncol. 2006 Dec 17;4:96.PMID: 17173703 [PubMed]Related articlesFree article

Response to "A Porsche for patient accrual," by David Steinberg, Cancer Investigation, 2005, 23(8), pp. 741-743.

Baker LH.

Cancer Invest. 2006 Apr-May;24(3):337. No abstract available. PMID: 16809165 [PubMed - indexed for MEDLINE]Related articles

Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.

McHugh JB, Thomas DG, Herman JM, Ray ME, Baker LH, Adsay NV, Rabah R, Lucas DR.

Cancer. 2006 Aug 1;107(3):554-62.PMID: 16795069 [PubMed - indexed for MEDLINE]Related articlesFree article

"What else?" Setting the agenda for the clinical interview.

Baker LH, O'connell D, Platt FW.

Ann Intern Med. 2005 Nov 15;143(10):766-70. No abstract available. PMID: 16287811 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.

Schott AF, Rae JM, Griffith KA, Hayes DF, Sterns V, Baker LH.

Cancer Chemother Pharmacol. 2006 Jul;58(1):129-35. Epub 2005 Nov 8.PMID: 16283312 [PubMed - indexed for MEDLINE]Related articles

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.

Schott AF, Roubidoux MA, Helvie MA, Hayes DF, Kleer CG, Newman LA, Pierce LJ, Griffith KA, Murray S, Hunt KA, Paramagul C, Baker LH.

Breast Cancer Res Treat. 2005 Aug;92(3):231-8.PMID: 16155794 [PubMed - indexed for MEDLINE]Related articles

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition.

Hughes DP, Thomas DG, Giordano TJ, McDonagh KT, Baker LH.

Pediatr Blood Cancer. 2006 May 1;46(5):614-23.PMID: 16007579 [PubMed - indexed for MEDLINE]Related articles

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.

Chugh R, Dunn R, Zalupski MM, Biermann JS, Sondak VK, Mace JR, Leu KM, Chandler WF, Baker LH.

J Clin Oncol. 2005 May 20;23(15):3597-604.PMID: 15908670 [PubMed - indexed for MEDLINE]Related articles

Medical and pediatric oncology, not adult and pediatric oncology.

Baker LH.

J Clin Oncol. 2005 Jun 20;23(18):4003-5. Epub 2005 Mar 14. No abstract available. PMID: 15767649 [PubMed - indexed for MEDLINE]Related articles

Soft tissue sarcoma clinical practice guidelines in oncology.

Demetri GD, Baker LH, Beech D, Benjamin R, Casper ES, Conrad EU 3rd, DeLaney TF, Ettinger DS, Heslin MJ, Hutchinson RJ, Kiel K, Kraybill WG, Letson GD, Neff J, O'Donnell RJ, Paz IB, Pollock RE, Randall RL, Schupak KD, Tyler DS, von Mehren M, Wayne J; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Mar;3(2):158-94. No abstract available. PMID: 19817028 [PubMed - indexed for MEDLINE]

Bone cancer clinical practice guidelines.

Biermann JS, Baker LH, Benjamin R, Brigman B, Chow W, Conrad EU 3rd, Frassica D, Frassica FJ, George S, Healey JH, Heck R, Letson GD, Mayerson J, Neff J, O'Donnell RJ, Randall RL, Santana V, Satcher RL, Schmidt RG, Siegel HJ, Wong MK, Yasko AW; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Mar;3(2):124-40. No abstract available. PMID: 19817025 [PubMed - indexed for MEDLINE]

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.

Worden FP, Taylor JM, Biermann JS, Sondak VK, Leu KM, Chugh R, McGinn CJ, Zalupski MM, Baker LH.

J Clin Oncol. 2005 Jan 1;23(1):105-12. Erratum in: J Clin Oncol. 2006 Sep 1;24(25):4223. PMID: 15625365 [PubMed - indexed for MEDLINE]Related articles

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.

Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, Lee JS, Couwlier C, Palazzolo K, Baker LH.

J Clin Oncol. 2004 May 1;22(9):1706-12.PMID: 15117993 [PubMed - indexed for MEDLINE]Related articles

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.

Hughes DP, Thomas DG, Giordano TJ, Baker LH, McDonagh KT.

Cancer Res. 2004 Mar 15;64(6):2047-53.PMID: 15026342 [PubMed - indexed for MEDLINE]Related articlesFree article

Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.

Mace JR, Keohan ML, Bernardy H, Junge K, Niebch G, Romeis P, Thoma A, Wagner T, Mueller U, Demetri G, Baker LH.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5829-34.PMID: 14676103 [PubMed - indexed for MEDLINE]Related articlesFree article

Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.

Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, Rees R, Sondak VK.

Cancer. 2003 Oct 15;98(8):1716-26.PMID: 14534889 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.

Cancer. 2003 Jul 15;98(2):331-6.PMID: 12872353 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma.

Dhaini HR, Thomas DG, Giordano TJ, Johnson TD, Biermann JS, Leu K, Hollenberg PF, Baker LH.

J Clin Oncol. 2003 Jul 1;21(13):2481-5.PMID: 12829666 [PubMed - indexed for MEDLINE]Related articles

Soft tissue sarcomas of adults: state of the translational science.

Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O'Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF.

Clin Cancer Res. 2003 Jun;9(6):1941-56. Review.PMID: 12796356 [PubMed - indexed for MEDLINE]Related articlesFree article

Connected: communication skills for nurses using the electronic medical record.

Baker LH, Reifsteck SW, Mann WR.

Nurs Econ. 2003 Mar-Apr;21(2):85-8. No abstract available. PMID: 12739199 [PubMed - indexed for MEDLINE]Related articles

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.

Thall PF, Wathen JK, Bekele BN, Champlin RE, Baker LH, Benjamin RS.

Stat Med. 2003 Mar 15;22(5):763-80.PMID: 12587104 [PubMed - indexed for MEDLINE]Related articles

Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report.

Munshi HG, Merajver SD, Valdez R, Baker LH, Cooney KA.

Am J Clin Oncol. 2002 Jun;25(3):274-6.PMID: 12040287 [PubMed - indexed for MEDLINE]Related articles

The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.

Hirth J, Watkins PB, Strawderman M, Schott A, Bruno R, Baker LH.

Clin Cancer Res. 2000 Apr;6(4):1255-8.PMID: 10778948 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson SK, Lew D, Miller GJ, Balcerzak SP, Baker LH, Crawford ED.

Cancer. 2000 Mar 1;88(5):1159-65.PMID: 10699907 [PubMed - indexed for MEDLINE]Related articlesFree article

Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.

Sugawara Y, Zasadny KR, Kison PV, Baker LH, Wahl RL.

J Nucl Med. 1999 Sep;40(9):1456-62.PMID: 10492365 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of cancer information on the Internet.

Biermann JS, Golladay GJ, Greenfield ML, Baker LH.

Cancer. 1999 Aug 1;86(3):381-90. No abstract available. PMID: 10430244 [PubMed - indexed for MEDLINE]Related articlesFree article

Soft tissue sarcoma: opening the door to advances in diagnosis and treatment.

Biermann JS, Baker LH.

Cancer. 1999 Jun 15;85(12):2497-8. No abstract available. PMID: 10375093 [PubMed - indexed for MEDLINE]Related articlesFree article

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.

Weiss GR, Liu PY, Alberts DS, Peng YM, Fisher E, Xu MJ, Scudder SA, Baker LH Jr, Moore DF, Lippman SM.

Gynecol Oncol. 1998 Dec;71(3):386-90.PMID: 9887236 [PubMed - indexed for MEDLINE]Related articles